Great article on $CRWG on #Cannabis! Cashing in on

New Post Public Reply Private Reply Replies (0) Message Board
langlui tommyboyboy #800
Great article on $CRWG on #Cannabis! Cashing in on Cannabis: CrowdGather's Smart Approach to Capturing Value From the Industry

REDONDO BEACH, CA / ACCESSWIRE / August 24, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while it's generally considered to be the fastest growing industry in the U.S. economy. While these dynamics should make the industry ripe for investment, the murky legality of industry on a federal level and the opaque nature of many existing publicly-traded companies in the space (that went public through reverse mergers) have made it treacherous for investors.

In this release, we'll take a look at CrowdGather's unique value proposition to investors interested in the cannabis industry.

Growing Institutional Interest

The cannabis industry has begun attracting significant levels of institutional interest. In January, venture capital heavyweight Peter Thiel announced that his $2 billion Founders Fund would be investing in Privateer Holdings, a marijuana company that owns several pot-related brands. The size of the investment wasn't officially disclosed, but insiders say that it was a "multimillion dollar" participation in Privateer's $75 million capital raise.

On a more granular level, ArcView Group has over 480 investor members that have invested over $45 million into 72 different companies. The group hosts webinars each week where up to five companies pitch investors, while offering large in-person events each quarter. With hundreds of high net worth individuals participating, the group has been an early pioneer in facilitating institutional level investments within the growing cannabis industry.

The common denominator is that these investments were all made in privately-held companies rather than publicly-traded companies. When it comes to traditional institutional investors - who may be limited to publicly-traded securities - there are fewer options. Many public companies have shaky finances, limited operating histories, and few disclosures when it comes to making regular filings with the Securities & Exchange Commission.

Ideal Risk-Free Exposure

CrowdGather operates a growing portfolio of special interest forums and scalable multi-platform games. In April, we announced the acquisition of digital assets including WeedTracker.com, DispensaryWeed.com, and WeedInHollywood.com as part of an effort to diversify its digital assets to capitalize on the growing cannabis industry. The diversification also is consistent with our overall focus of accumulating online users and monetizing them.

While companies like GW Pharmaceuticals plc (NASDAQ:GWPH) and Cannabis Science Inc. (CBIS) are pursuing clinical trials, our business model enables them to immediately capitalize on the information component of the growing industry without relying on regulatory approvals to begin realizing revenue by providing web services to cannabis consumers and then generating revenue from advertising.

We plan on building out WeedTracker.com into a fully-featured on-line cannabis community, while turning WeedInHollywood.com into its first cannabis themed gaming title. Beyond these efforts, our management hopes to become a nexus for the entire digital cannabis movement by designing a crowdfunding platform focused on cannabis that it intends to launch on its root domain - CrowdGather.com - in early 2016.

Our Business Model

Our social gaming business generated nearly $700,000 in revenue at a 75% gross margin during the three-months ended January 31, 2015, creating a base upon which to grow its newly acquired cannabis-focused businesses. Management believes the addition of high-growth cannabis opportunities on top of its existing business creates an opportunity for institutional and retail investors to get involved in the potential upside.

According to YCharts, the company's stock is trading more than 40% below its historical valuation of $0.0872, and we believe, below our enterprise value, and with an attractive price-book ratio. We believe these dynamics suggest that the stock may be undervalued based on its assets and historical valuations, despite the addition of its new gaming and cannabis-focused businesses that have the potential to create its opportunities.

The company's management has also been making changes to the cost structure aimed at improving profitability. In May of last year, the company sold off some of its legacy assets in order to shore up its balance sheet and raise cash. While platform fees and payroll costs have risen from its subsequent Plaor acquisition, we believe that ongoing revenue growth will offset and leverage these higher expenses as it achieves scale.

Looking Ahead

We believe CrowdGather offers an opportunity to capitalize on the rapidly growing cannabis industry without taking on any of the regulatory risk. In addition, the company has the added benefit of a rapidly growing gaming business and an equity that is trading at a compelling valuation. We hope Investors in the cannabis industry, including those involved with companies like Surna Inc. (SRNA) and MaryJane Group Inc. (MJMJ), may want to take a closer look at our stock.

During its last fiscal year, the company reported revenue that increased 51% to $2.4 million and a net loss ($7.1 million) on a per share basis that was cut in half from ($0.13) to ($0.06) per share. The majority of these results were realized from its social gaming division, which accounted for about three-quarters of revenue, while forum revenue accounted for much of the remainder. Management's daily bookings and other metrics have also been increasing.

As a vote of confidence in our future prospects, CrowdGather CEO Sanjay Sabnani has also been an active buyer of the stock in the open market, having purchased 50,000 shares in mid-June of this year at prices of $0.075 to $0.08 per share, according to Form 4 filings with the SEC. Additionally, Sabnani provided bridge financing to the company earlier this year of $270,000. These actions suggest that Mr. Sabnani remains confident in the company's future and believes that the current price of the stock may be undervalued.

To learn more, visit the company's website at www.crowdgather.com.

Read Full: http://finance.yahoo.com/news/cashing-cannabi...00557.html

Perigee Holdings Inc (PEHD) Stock Research Links

PEHD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 1

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 2

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cofactor Genomics Appoints New CEO to Enhance Patient Access

Updated Category News Views 169

Cofactor Genomics Appoints Chris Parker as New CEO Cofactor Genomics, Inc., a commercial-stage company dedicated to bridging the precision medicine gap through RNA decoding, has announced a significant leadership transition. Chris Parker has been appointed as the new CEO and Board Member, succeeding Jarret Glasscock, who will continue his contributions in the roles of...

Continue Reading
Minto Apartment REIT Declares Cash Distribution for July 2025

Updated Category News Views 168

Minto Apartment REIT's Cash Distribution Announcement Minto Apartment Real Estate Investment Trust (MI) has recently made an important announcement regarding its cash distribution. The REIT has declared a monthly cash distribution of $0.04333 per unit for the month of July 2025. This translates to an annualized rate of $0.52 per unit. The payment is set to be distributed...

Continue Reading
National Geographic–Lindblad Expands Alaska Offerings for Travelers

Updated Category News Views 89

Expanding Exploration: National Geographic–Lindblad's New Chapter in Alaska National Geographic–Lindblad Expeditions is celebrating a significant milestone in its quest to enhance adventure travel in Alaska, with plans to expand its offerings starting in 2027. The company is known for its pioneering spirit and leadership in expedition travel, and this expansion is a...

Continue Reading
Brian Krause Takes the Helm as Chief Development Officer at Panera

Updated Category News Views 453

Brian Krause Appointed as Chief Development Officer at Panera Bread Panera Bread, a leader in the fast casual dining sector, has recently announced the appointment of Brian Krause as its new Chief Development Officer. With a wealth of experience in franchise development and strategic growth, Krause aims to propel the company's expansion plans. Krause's Experience and...

Continue Reading
Strategic Growth Ahead for Blockmate Ventures with New Funding

Updated Category News Views 115

Blockmate Ventures Expands Its Horizons with New Investment Blockmate Ventures Inc. (TSX.V: MATE), a company recognized for its innovative approach in the tech world, has recently announced a significant investment commitment of CAD $1,400,000. This strategic funding comes from a group of investors, featuring notable industry figure Antanas Guoga, popularly known as Tony...

Continue Reading